 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$1.77 |
$1.77 |
$1.66 |
$1.69 |
506.90K | | 04/17/2024 |
$1.69 |
$1.72 |
$1.65 |
$1.67 |
267.80K | | 04/18/2024 |
$1.68 |
$1.72 |
$1.59 |
$1.60 |
469.50K | | 04/19/2024 |
$1.62 |
$1.68 |
$1.45 |
$1.46 |
763.60K | | 04/22/2024 |
$1.50 |
$1.54 |
$1.41 |
$1.45 |
459.50K |
|
|
| Checkpoint Therapeutics is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of treatments for patients with solid tumor cancers. Co. is evaluating its primary antibody product candidate, cosibelimab, an anti-programmed death-ligand 1 antibody, in an ongoing global, open-label, multicohort clinical trial in checkpoint therapy-naive patients with selected recurrent or metastatic cancers. Co. is also evaluating its main small-molecule, targeted anti-cancer agent, olafertinib, an epidermal growth factor receptor (EGFR) inhibitor, as a potential treatment for patients with EGFR mutation-positive non-small cell lung cancer. | |
|
Checkpoint Therapeutics (CKPT) has the following price history information. Looking back at CKPT historical stock prices for the last five trading days, on April 16, 2024, CKPT opened at $1.77, traded as high as $1.77 and as low as $1.66, and closed at $1.69. Trading volume was a total of 506.90K shares. On April 17, 2024, CKPT opened at $1.69, traded as high as $1.72 and as low as $1.65, and closed at $1.67. Trading volume was a total of 267.80K shares. On April 18, 2024, CKPT opened at $1.68, traded as high as $1.72 and as low as $1.59, and closed at $1.60. Trading volume was a total of 469.50K shares. On April 19, 2024, CKPT opened at $1.62, traded as high as $1.68 and as low as $1.45, and closed at $1.46. Trading volume was a total of 763.60K shares. On April 22, 2024, CKPT opened at $1.50, traded as high as $1.54 and as low as $1.41, and closed at $1.45. Trading volume was a total of 459.50K shares.
CKPT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Checkpoint Therapeutics shares, starting with a $10,000 purchase of CKPT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/28/2017 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$100.00 |
|
| End price/share: |
$1.45 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.55% |
|
| Average Annual Total Return: |
-46.24% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$144.95 |
|
| Years: |
6.82 |
|
|
|
| Date |
Close |
| 04/16/2024 | $1.69 | | 04/17/2024 | $1.67 | | 04/18/2024 | $1.60 | | 04/19/2024 | $1.46 | | 04/22/2024 | $1.45 |
|
|
Free CKPT Email Alerts:
